https://nexotx.com/2023/07/26/nexo-therapeutics-launches-with-60-million-series-a-financing/2023-07-26T14:00:00+02:00https://nexotx.com/2023/07/26/md-anderson-and-nexo-therapeutics-announce-strategic-research-collaboration-to-advance-new-therapies-against-intractable-targets/2023-07-26T13:00:00+02:00https://nexotx.com/2023/07/27/cen-nexo-launches-with-oncology-drug-discovery-program/2023-07-27T11:00:00+02:00https://nexotx.com/2023/07/27/medcity-news-bio-startup-nexo-lands-60m-to-climb-to-new-heights-in-cancer-drug-rd/2023-07-27T20:32:00+02:00https://nexotx.com/2023/07/27/pharmaceutical-technology-oncology-company-nexo-therapeutics-raises-60m-in-series-a-round/2023-07-27T16:00:00+02:00https://nexotx.com/2023/08/04/bioworld-nexo-emerges-with-60m-series-a-takes-aim-at-elusive-targets/2023-08-04T14:00:00+02:00https://nexotx.com/2023/07/26/biopharma-dive-nexo-allies-with-md-anderson-in-pursuit-of-covalent-cancer-drugs/2023-07-26T17:00:00+02:00